These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2960779)

  • 1. ATP as a marker of excitotoxin-induced nerve cell death in vivo.
    Vezzani A; Sangalli L; Wu HQ; Schwarcz R
    J Neural Transm; 1987; 70(3-4):349-56. PubMed ID: 2960779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The organotypic tissue culture model of corticostriatal system used for examining amino acid neurotoxicity and its antagonism: studies on kainic acid, quinolinic acid and (-) 2-amino-7-phosphonoheptanoic acid.
    Whetsell WO; Schwarcz R
    J Neural Transm Suppl; 1983; 19():53-63. PubMed ID: 6321650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve cell death induced in vivo by kainic acid and quinolinic acid does not involve apoptosis.
    Ignatowicz E; Vezzani AM; Rizzi M; D'Incalci M
    Neuroreport; 1991 Nov; 2(11):651-4. PubMed ID: 1839770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid.
    Foster AC; Vezzani A; French ED; Schwarcz R
    Neurosci Lett; 1984 Aug; 48(3):273-8. PubMed ID: 6237279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal damage in the albino rat: excitotoxin, microtubule inhibitor synergism.
    Cohen MR; Sridhara N; McElveen TS; Gutman R
    Life Sci; 1988; 43(13):1039-44. PubMed ID: 2971848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolinic acid neurotoxicity: protection by intracerebral phenylisopropyladenosine (PIA) and potentiation by hypotension.
    Connick JH; Stone TW
    Neurosci Lett; 1989 Jun; 101(2):191-6. PubMed ID: 2771165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal grafts provide sustained protection from kainic and quinolinic acid-induced damage.
    Tulipan N; Luo SQ; Allen GS; Whetsell WO
    Exp Neurol; 1988 Dec; 102(3):325-32. PubMed ID: 2973990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds.
    Foster AC; Collins JF; Schwarcz R
    Neuropharmacology; 1983 Dec; 22(12A):1331-42. PubMed ID: 6229703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons.
    Manfridi A; Forloni GL; Vezzani A; Fodritto F; De Simoni MG
    Neuroscience; 1991; 41(1):127-35. PubMed ID: 1676138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical characterization of excitotoxin lesions in the cerebral cortex.
    Beal MF; Swartz KJ; Finn SF; Mazurek MF; Kowall NW
    J Neurosci; 1991 Jan; 11(1):147-58. PubMed ID: 1670782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins.
    Miyamoto M; Coyle JT
    Exp Neurol; 1990 Apr; 108(1):38-45. PubMed ID: 2138566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolinate neurotoxicity and glutamatergic structures.
    Keilhoff G; Wolf G; Stastný F; Schmidt W
    Neuroscience; 1990; 34(1):235-42. PubMed ID: 1970138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxic effects of endogenous materials: quinolinic acid, L-pyroglutamic acid, and thyroid releasing hormone (TRH).
    McGeer EG; Singh E
    Exp Neurol; 1984 Nov; 86(2):410-3. PubMed ID: 6436049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor selectively prevents excitotoxin induced degeneration of striatal cholinergic neurones.
    Davies SW; Beardsall K
    Neurosci Lett; 1992 Jun; 140(2):161-4. PubMed ID: 1386916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolinic acid-induced seizures, but not nerve cell death, are associated with extracellular Ca2+ decrease assessed in the hippocampus by brain dialysis.
    Vezzani A; Wu HQ; Angelico P; Stasi MA; Samanin R
    Brain Res; 1988 Jun; 454(1-2):289-97. PubMed ID: 2970276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolinate and kainate neurotoxicity in neostriatal cultures is potentiated by co-culturing with neocortical neurons.
    Galarraga E; Surmeier DJ; Kitai ST
    Brain Res; 1990 Apr; 512(2):269-76. PubMed ID: 1972342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydroaminoacridine potentiates neurotoxicity of quinolinic acid in rat striatum.
    Zhu SG; McGeer EG; Singh EA; McGeer PL
    Neurosci Lett; 1988 Dec; 95(1-3):252-6. PubMed ID: 2976129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
    Foster AC; Gill R; Woodruff GN
    J Neurosci; 1988 Dec; 8(12):4745-54. PubMed ID: 2904493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of kainic acid and quinolinic acid toxicity by neostriatal transplants in vitro.
    Whetsell WO; Allen GS; Tulipan NB
    Neurosci Lett; 1989 Jan; 96(1):18-22. PubMed ID: 2522604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.